Prestige Consumer Healthcare Inc. (NYSE:PBH) EVP Adel Mekhail Sells 9,063 Shares

Prestige Consumer Healthcare Inc. (NYSE:PBH) EVP Adel Mekhail sold 9,063 shares of Prestige Consumer Healthcare stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $82.00, for a total transaction of $743,166.00. Following the completion of the sale, the executive vice president now directly owns 18,365 shares in the company, valued at approximately $1,505,930. This represents a 33.04 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Prestige Consumer Healthcare Stock Up 0.6 %

Shares of NYSE:PBH traded up $0.49 during midday trading on Thursday, reaching $82.81. The company’s stock had a trading volume of 337,716 shares, compared to its average volume of 250,663. The firm has a 50 day moving average of $72.98 and a 200-day moving average of $70.09. The firm has a market capitalization of $4.09 billion, a P/E ratio of 20.05, a PEG ratio of 2.30 and a beta of 0.47. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. Prestige Consumer Healthcare Inc. has a 12-month low of $56.61 and a 12-month high of $83.83.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $1.09 EPS for the quarter, meeting the consensus estimate of $1.09. The company had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. Prestige Consumer Healthcare’s revenue for the quarter was down .9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.07 EPS. On average, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Wall Street Analyst Weigh In

PBH has been the subject of a number of research reports. DA Davidson reissued a “buy” rating and issued a $95.00 price target on shares of Prestige Consumer Healthcare in a research note on Monday. Jefferies Financial Group reiterated a “hold” rating and set a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $94.20.

Institutional Trading of Prestige Consumer Healthcare

Institutional investors have recently made changes to their positions in the stock. Martingale Asset Management L P raised its stake in Prestige Consumer Healthcare by 0.4% during the 3rd quarter. Martingale Asset Management L P now owns 36,971 shares of the company’s stock worth $2,666,000 after acquiring an additional 140 shares during the period. Covestor Ltd grew its holdings in shares of Prestige Consumer Healthcare by 21.6% in the first quarter. Covestor Ltd now owns 834 shares of the company’s stock valued at $61,000 after purchasing an additional 148 shares in the last quarter. Horizon Kinetics Asset Management LLC grew its holdings in shares of Prestige Consumer Healthcare by 4.8% in the third quarter. Horizon Kinetics Asset Management LLC now owns 3,247 shares of the company’s stock valued at $234,000 after purchasing an additional 150 shares in the last quarter. Evergreen Capital Management LLC grew its holdings in shares of Prestige Consumer Healthcare by 5.4% in the second quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company’s stock valued at $216,000 after purchasing an additional 160 shares in the last quarter. Finally, Miller Howard Investments Inc. NY boosted its stake in Prestige Consumer Healthcare by 2.2% during the second quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company’s stock worth $534,000 after buying an additional 165 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.